Cytokines sing the blues: Inflammation and the pathogenesis of depression

Trends in Immunology

Volumn 27, Issue 1, 2006, Pages 24-31

  Raison, Charles L ^a   Capuron, Lucile ^a   Miller, Andrew H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA INTERFERON; ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CHEMOKINE; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; CYTOKINE RECEPTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; BEHAVIOR; CHOLINERGIC SYSTEM; DEPRESSION; HUMAN; INFLAMMATION; MENTAL STRESS; NERVE CELL PLASTICITY; NEUROENDOCRINE SYSTEM; PATHOGENESIS; PATHOPHYSIOLOGY; PSYCHOTHERAPY; REVIEW;

ANIMALS; BEHAVIOR; CYTOKINES; DEPRESSION; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; STRESS; STRESS, PHYSIOLOGICAL;

EID: 30544445602     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2005.11.006     Document Type: Review

References (91)

1. T.B. Herbert, and S. Cohen Depression and immunity: a meta-analytic review Psychol. Bull. 113 1993 472 486
2. K.E. Wellen, and G.S. Hotamisligil Inflammation, stress, and diabetes J. Clin. Invest. 115 2005 1111 1119
3. Willerson, J.T. and Ridker, P.M. (2004) Inflammation as a cardiovascular risk factor. Circulation 109 (21, Suppl 1), II2-10
4. Q. Li Inflammation-associated cancer: NF-kappaB is the lynchpin Trends Immunol 26 2005 318 325
5. D.L. Evans Mood disorders in the medically ill: scientific review and recommendations Biol. Psychiatry 58 2005 175 189
6. S. Alesci Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications J. Clin. Endocrinol. Metab. 90 2005 2522 2530
7. G.E. Miller Clinical depression and inflammatory risk markers for coronary heart disease Am. J. Cardiol. 90 2002 1279 1283
8. A.L. Bouhuys Potential psychosocial mechanisms linking depression to immune function in elderly subjects Psychiatry Res. 127 2004 237 245
9. D.L. Musselman Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings Am. J. Psychiatry 158 2001 1252 1257
10. K.G. Kahl Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder Am. J. Psychiatry 162 2005 168 174
11. H. Tiemeier Inflammatory proteins and depression in the elderly Epidemiology 14 2003 103 107
12. J. Schlatter Monocytic parameters in patients with dysthymia versus major depression J. Affect. Disord. 78 2004 243 247
13. D.E. Ford, and T.P. Erlinger Depression and C-reactive protein in US adults Arch. Intern. Med. 164 2004 1010 1014
14. M. Danner Association between depression and elevated C-reactive protein Psychosom. Med. 65 2003 347 356
15. M. Maes Major depression and activation of the inflammatory response system Adv. Exp. Med. Biol. 461 1999 25 46
16. J. Levine Cerebrospinal cytokine levels in patients with acute depression Neuropsychobiology 40 1999 171 176
17. S. Lanquillon Cytokine production and treatment response in major depressive disorder Neuropsychopharmacology 22 2000 370 379
18. S. Rajagopalan Abnormal brachial artery flow-mediated vasodilation in young adults with major depression Am. J. Cardiol. 88 2001 196 198
19. A. Sluzewska Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine Ann. N. Y. Acad. Sci. 762 1995 474 476
20. M. Maes Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression Cytokine 9 1997 853 858
21. O. Mikova Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis Eur. Neuropsychopharmacol. 11 2001 203 208
22. A. Sluzewska Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression Neuropsychobiology 35 1997 123 127
23. C. Tuglu Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder Psychopharmacology (Berl.) 170 2003 429 433
24. K.A. Hestad Raised plasma levels of tumor necrosis factor alpha in patients with depression J. ECT 19 2003 183 188
25. B.M. Owen Raised levels of plasma interleukin-1beta in major and postviral depression Acta Psychiatr. Scand. 103 2001 226 228
26. A.J. Thomas Increase in interleukin-1beta in late-life depression Am. J. Psychiatry 162 2005 175 177
27. Y.W. Yu Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response Neuropsychopharmacology 28 2003 1182 1185
28. T.Y. Jun Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population Psychiatr. Genet. 13 2003 179 181
29. E.C. Suarez Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women Psychoneuroendocrinology 29 2004 1119 1128
30. A. van der Ven Herpes viruses, cytokines, and altered hemostasis in vital exhaustion Psychosom. Med. 65 2003 194 200
31. M. Irwin Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African American alcoholics Brain Behav. Immun. 18 2004 349 360
32. E.C. Suarez The relation of aggression, hostility, and anger to lipopolysaccharide-stimulated tumor necrosis factor (TNF)-alpha by blood monocytes from normal men Brain Behav. Immun. 16 2002 675 684
33. F. Lesperance The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes Am. J. Psychiatry 161 2004 271 277
34. G.E. Miller Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes Am. J. Cardiol. 95 2005 317 321
35. J.E. Bower Fatigue and proinflammatory cytokine activity in breast cancer survivors Psychosom. Med. 64 2002 604 611
36. C.A. Meyers Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome Cancer 104 2005 788 793
37. M. Haack Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis J. Psychiatr. Res. 33 1999 407 418
38. A. Steptoe Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women Psychol. Med. 33 2003 667 674
39. G.E. Miller Pathways linking depression, adiposity, and inflammatory markers in healthy young adults Brain Behav. Immun. 17 2003 276 285
40. S.J. Motivala Inflammatory markers and sleep disturbance in major depression Psychosom. Med. 67 2005 187 194
41. S.T. Szabo Neurotransmitters, receptors, signal transduction, and second messengers in psychiatric disorders A.F. Schatzberg C.B. Nemeroff Textbook of Psychopharmacology 2004 American Psychiatric Publishing 3 52
42. M.J. Owens, and C.B. Nemeroff Physiology and pharmacology of corticotropin-releasing factor Pharmacol. Rev. 43 1991 425 473
43. C.L. Raison, and A.H. Miller When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders Am. J. Psychiatry 160 2003 1554 1565
44. C.M. Pariante, and A.H. Miller Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment Biol. Psychiatry 49 2001 391 404
45. M. Martinot Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation Am. J. Psychiatry 158 2001 314 316
46. W.C. Drevets Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders Curr. Opin. Neurobiol. 11 2001 240 249
47. R.S. Duman Depression: a case of neuronal life and death? Biol. Psychiatry 56 2004 140 145
48. S.F. Maier, and L.R. Watkins Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition Psychol. Rev. 105 1998 83 107
49. R. Dantzer Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity Eur. J. Pharmacol. 500 2004 399 411
50. H.M. Gao Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease J. Neurochem. 81 2002 1285 1297
51. A.J. Dunn Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress Adv. Exp. Med. Biol. 461 1999 117 127
52. H.O. Besedovsky, and A. del Rey Immune-neuro-endocrine interactions: facts and hypotheses Endocr. Rev. 17 1996 64 102
53. M.N. Silverman Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection Viral Immunol. 18 2005 41 78
54. L. Capuron, and A.H. Miller Cytokines and psychopathology: lessons from interferon-alpha Biol. Psychiatry 56 2004 819 824
55. X. Wang Interleukin-1 alpha-induced activation of p38 mitogen-activated kinase inhibits glucocorticoid receptor function Mol. Psychiatry 9 2004 65 75
56. L.I. McKay, and J.A. Cidlowski Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways Endocr. Rev. 20 1999 435 459
57. C.B. Zhu p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process J. Biol. Chem. 280 2005 15649 15658
58. Nadjar, A. et al. Inactivation of the cerebral NFkappaB pathway inhibits interleukin-1beta-induced sickness behavior and c-Fos expression in various brain nuclei. Neuropsychopharmacology (in press)
59. T. Lu Gene regulation and DNA damage in the ageing human brain Nature 429 2004 883 891
60. J.L. Madrigal The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress Neuropsychopharmacology 26 2002 155 163
61. D.L. Musselman Paroxetine for the prevention of depression induced by high-dose interferon alfa N. Engl. J. Med. 344 2001 961 966
62. L. Capuron Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy Mol. Psychiatry 7 2002 468 473
63. L. Capuron Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy Am. J. Psychiatry 160 2003 1342 1345
64. F.D. Juengling Prefrontal cortical hypometabolism during low-dose interferon alpha treatment Psychopharmacology (Berl.) 152 2000 383 389
65. L. Capuron Anterior cingulate activation and error processing during interferon-alpha treatment Biol. Psychiatry 58 2005 190 196
66. K.S. Kendler Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the 'kindling' hypothesis Am. J. Psychiatry 157 2000 1243 1251
67. K.A. O'Connor Peripheral and central proinflammatory cytokine response to a severe acute stressor Brain Res. 991 2003 123 132
68. C.R. Pugh Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation Behav. Brain Res. 106 1999 109 118
69. R.M. Barrientos Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist Neuroscience 121 2003 847 853
70. M.U. Goebel Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways Psychosom. Med. 62 2000 591 598
71. R. Deinzer Acute stress effects on local Il-1beta responses to pathogens in a human in vivo model Brain Behav. Immun. 18 2004 458 467
72. M. Maes The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety Cytokine 10 1998 313 318
73. A. Bierhaus A mechanism converting psychosocial stress into mononuclear cell activation Proc. Natl. Acad. Sci. U. S. A. 100 2003 1920 1925
74. A. Moraska Elevated IL-1beta contributes to antibody suppression produced by stress J. Appl. Physiol. 93 2002 207 215
75. D.R. Murray Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression Circulation 101 2000 2338 2341
76. B. Mayer Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels Int. J. Cardiol. 103 2005 182 186
77. V.A. Pavlov, and K.J. Tracey The cholinergic anti-inflammatory pathway Brain Behav. Immun. 19 2005 493 499
78. I. Janszky Inflammatory markers and heart rate variability in women with coronary heart disease J. Intern. Med. 256 2004 421 428
79. C.K. Kim Depressive symptoms and heart rate variability in postmenopausal women Arch. Intern. Med. 165 2005 1239 1244
80. R. Avitsur Social stress induces glucocorticoid resistance in subordinate animals Horm. Behav. 39 2001 247 257
81. G. Kenis, and M. Maes Effects of antidepressants on the production of cytokines Int. J. Neuropsychopharmacol. 5 2002 401 412
82. J.L. Reynolds Brain-derived tumor necrosis factor-alpha and its involvement in noradrenergic neuron functioning involved in the mechanism of action of an antidepressant J. Pharmacol. Exp. Ther. 310 2004 1216 1225
83. U.H. Frommberger Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission Eur. Arch. Psychiatry Clin. Neurosci. 247 1997 228 233
84. F. Benedetti Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance Prog. Neuropsychopharmacol. Biol. Psychiatry 26 2002 1167 1170
85. L. Capuron Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions Neuropsychopharmacology 26 2002 643 652
86. G.R. Morrow Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program J. Clin. Oncol. 21 2003 4635 4641
87. T. Greco The outcome of physical symptoms with treatment of depression J. Gen. Intern. Med. 19 2004 813 818
88. S.F. Maier, and L.R. Watkins Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock Brain Res. 695 1995 279 282
89. G.R. Lichtenstein Infliximab improves quality of life in patients with Crohn's disease Inflamm. Bowel Dis. 8 2002 237 243
90. S.D. Mathias Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo Clin. Therap. 22 2000 128 139
91. th edn 2000 American Psychiatric Association